Anaptysbio Inc $ANAB

Recent News (6)

• Anaptys Announces Participation at the H.C. Wainwright 28th Annual Global Investment Conference GlobeNewswire · 01 Sep 2026 SAN DIEGO, Sept. 01, 2026 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a company focused on managing the financial collaborations for Jemperli with GSK and imsidolimab with Vanda, today anno…
• AnaptysBio earnings on deck: Can Jemperli offset revenue slide? Investing.com · 30 Aug 2026 AnaptysBio earnings on deck: Can Jemperli offset revenue slide?
• DQS Inc. Achieves ANAB Accreditation for ISO 14001:2026 PR Newswire · 24 Aug 2026 Updated accreditation enables DQS Inc. to certify organizations to the revised environmental management systems standard SCHAUMBURG, Ill., Aug. 24, 2026 /PRNewswire/ -- DQS Inc. today announced it is …
• KPMG PRI becomes first verification body accredited by ANAB for Section 45Z clean fuel certifications PR Newswire · 24 Aug 2026 New accreditation scope supports independent certification of fuel production and carbon-intensity information for U.S. clean-fuel producers CHICAGO, Aug. 24, 2026 /PRNewswire/ -- KPMG Performance Reg…
• Analysts Offer Insights on Healthcare Companies: Protagonist Therapeutics (PTGX), UnitedHealth (UNH) and AnaptysBio (ANAB) The Globe and Mail · 22 Jul 2026 Analysts Offer Insights on Healthcare Companies: Protagonist Therapeutics (PTGX), UnitedHealth (UNH) and AnaptysBio (ANAB)  The Globe and Mail
• Analysts Offer Insights on Healthcare Companies: Protagonist Therapeutics (PTGX), UnitedHealth (UNH) and AnaptysBio (ANAB) The Globe and Mail · 22 Jul 2026 Analysts Offer Insights on Healthcare Companies: Protagonist Therapeutics (PTGX), UnitedHealth (UNH) and AnaptysBio (ANAB)  The Globe and Mail